OC
ACLS icon

Oppenheimer & Co’s Axcelis ACLS Stock Holding History

Oppenheimer & Co’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,256
Closed -$436K – 1647
2025
Q2 		$436K Sell
6,256
-250
-4% -$14.3K 0.01% 1190
2025
Q1 		$323K Buy
6,506
+499
+8% +$31.6K ﹤0.01% 1238
2024
Q4 		$420K Buy
6,007
+1,307
+28% +$109K 0.01% 1125
2024
Q3 		$493K Buy
+4,700
New +$550K 0.01% 1033
2023
Q4 		– Sell
-1,654
Closed -$270K – 1384
2023
Q3 		$270K Buy
+1,654
New +$291K 0.01% 1163

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Oppenheimer & Co's ACLS Position: Q3 2025 in Review

Oppenheimer & Co sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 6,256 shares — an estimated $436K sold.

Oppenheimer & Co first reported a position in ACLS in Q3 2023 and held it in 5 quarters. The position peaked at $493K in Q3 2024. 361 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.

  • Oppenheimer & Co reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 6,256 Axcelis shares in Q3 2025, an estimated $436K.
  • Oppenheimer & Co first reported a position in Axcelis in Q3 2023 and held it in 5 quarters.
  • Oppenheimer & Co's Axcelis position peaked at $493K in Q3 2024.
  • 361 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.

Based on Oppenheimer & Co's 13F filing for Q3 2025, filed 6 Nov 2025.